Aller au contenu principal
Profil bibliographique

Meg K. Tully

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
12Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Malaria Research and ControlAir Quality and Health ImpactsComputational Drug Discovery MethodsPharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Les publications récentes

Accès ouvert 2025 article OpenAlex

Quantification of cure for pharmacodynamic models of antimalarial drugs: Deterministic versus stochastic approaches

Meg K. Tully, Robert J. Commons, J. A. Simpson, David J. Price

In silico pharmacokinetic-pharmacodynamic (PK-PD) models are used to inform dose optimisation in antimalarial drug development. Here the PK-PD models capture the change in parasite count over time because of exposure to antimalarial drug(s). For current deterministic PD models, simulated parasite numbers decline …

au, gb (code pays fourni par la source)

0 citations British Journal of Clinical Pharmacology
Accès ouvert 2025 article OpenAlex

The associations between gas cooking stoves, indoor NO2 concentrations, and adverse sleep outcomes in a pediatric sample

Jing Wang, Seyni Gueye‐Ndiaye, Xiaoyu Li, Sanjana Bhaskar et autres

STUDY OBJECTIVES: To investigate whether gas cooking stove exposure and elevated indoor nitrogen dioxide (NO2) concentration were associated with adverse sleep outcomes in a pediatric sample. METHODS: Children from urban neighborhoods in Boston, Massachusetts underwent in-home sleep assessments. Indoor NO2 concentrations were …

us, cn (code pays fourni par la source)

0 citations SLEEP
Accès ouvert 2025 preprint OpenAlex

Quantification of cure for pharmacodynamic models of antimalarial drugs: deterministic versus stochastic approaches

Meg K. Tully, Ruiz Francisco J., J. A. Simpson

In silico pharmacokinetic-pharmacodynamic (PK-PD) models are used to inform dose optimisation in antimalarial drug development. Here the PK-PD models capture the change in parasite count over time due to exposure to antimalarial drug(s). For current deterministic PD models, simulated parasite numbers decline …

au (code pays fourni par la source)

0 citations
Accès ouvert 2024 article OpenAlex

Evaluation of a Bayesian hierarchical pharmacokinetic–pharmacodynamic model for predicting parasitological outcomes in Phase 2 studies of new antimalarial drugs

Meg K. Tully, S Dini, Jennifer A. Flegg, James McCarthy et autres

The rise of multidrug-resistant malaria requires accelerated development of novel antimalarial drugs. Pharmacokinetic-pharmacodynamic (PK-PD) models relate blood antimalarial drug concentrations with the parasite-time profile to inform dosing regimens. We performed a simulation study to assess the utility of a Bayesian hierarchical mechanistic …

au, gb (code pays fourni par la source)

0 citations Antimicrobial Agents and Chemotherapy
Accès ouvert 2024 preprint OpenAlex

Evaluation of a Bayesian hierarchical pharmacokinetic-pharmacodynamic model for predicting parasitological outcomes in Phase 2 studies of new antimalarial drugs

Meg K. Tully, S Dini, Jennifer A. Flegg, James McCarthy et autres

Abstract The rise of multidrug resistant malaria requires accelerated development of novel antimalarial drugs. Pharmacokinetic-pharmacodynamic (PK-PD) models relate blood antimalarial drug concentrations with the parasite-time profile to inform dosing regiments. We performed a simulation study to assess the utility of a Bayesian …

au (code pays fourni par la source)

0 citations medRxiv

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.